Sir,

We wish to comment on the article entitled "Iron Sucrose Versus Oral Iron Therapy in Pregnancy Anemia" published in October 2012 issue of Indian Journal of Community Medicine.([@ref1]) The research communication was extremely informative keeping in view of high prevalence of anemia amongst pregnant women 58.7% (\<12.0 g/dl) and non-pregnant women 55.3% (\<12.0 g/dl) as per National Family Health Survey-3 (NFHS-3) 2005-06 data.([@ref2])

The investigators found that there was a mean increase of hemoglobin of 1.31 g/dl in oral iron group and 2.06 g/dl in intravenous group. The small increase in hemoglobin may be because there are other causes of anemia like micronutrient deficiencies (e.g., folate, B~12~ and Vitamin A deficiencies), helminthic infestations, malaria and hemoglobinopathies. The investigators found that there was an increase in hemoglobin in oral iron group from 9.75 g/dl to 11.06 g/dl and in intravenous iron group from 9.18 g/dl to 11.24 g/dl.

It would have been scientifically more valid if the increase in hemoglobin amongst the mothers at different levels of hemoglobin viz: Hb 7-8 g/dl, 8-9 g/dl, 9-10 g/dl and 10-11 g/dl in two groups is shared with readers of IJCM. This information would be important for policy makers.

The pregnant women of hemoglobin 6.5 g/dl were included in the study, who was suffering from severe anemia. This is ethically wrong as these women require treatment.
